A potent dual-action ophthalmic solution combining a fourth-generation fluoroquinolone antibiotic with a powerful non-steroidal anti-inflammatory drug (NSAID). METILET-K is specifically formulated to simultaneously eradicate bacterial infections and provide rapid relief from intense ocular pain and post-surgical inflammation.
Synergistic Antibacterial and Anti-Inflammatory Action
METILET-K provides a comprehensive approach to ocular care by combining Moxifloxacin 0.5% and Ketorolac Tromethamine 0.5%. While the antibiotic eliminates the underlying infection, the NSAID component targets the inflammatory pathways to stop pain, swelling, and redness at the source.
Advanced Fourth-Generation Bactericidal Power:
Moxifloxacin is a high-potency fluoroquinolone that inhibits both DNA gyrase and Topoisomerase IV. This dual-action mechanism prevents bacterial replication and repair, ensuring the rapid destruction of a broad spectrum of Gram-positive and Gram-negative pathogens, including resistant strains.
Rapid Relief from Ocular Pain and Discomfort
Ketorolac Tromethamine 0.5% is a highly effective NSAID that inhibits the synthesis of prostaglandins. It provides localized analgesic and anti-inflammatory effects, making it the clinical gold standard for managing the sharp pain and "gritty" sensation associated with corneal trauma or surgery.